Forbes October 8, 2024
Demaris Mills is president at Integrated DNA Technologies, a global genomics solutions provider.
The past seven years have brought a remarkable boom in genomics medicine. The first CAR-T cell therapy for cancer—genetically modified to recognize individual patients’ cancers—was approved by the U.S. Food and Drug Administration in 2017, with five additional CAR-Ts approved since. The first mRNA vaccines, developed in record time to treat Covid-19, hit the market in 2021. Seven gene therapies to correct inherited diseases have been approved, and in December 2023, the FDA green-lighted the first CRISPR gene-editing therapy to treat sickle cell disease.
It’s truly exciting to imagine what the next generation of genomics medicines will offer for patients. A staggering 2,093 CAR-Ts, gene therapies and...
Today's Sponsors
Today's Sponsor